NETGEAR, Akers Biosciences, and TOP Ships to Appear on RedChip TV on Bloomberg
GlobeNewswire - Wed Oct 08, 10:46AM CDT
RedChip Companies, Inc. ("RedChip"
TOPS: 1.81 (+0.16), AKER: 3.55 (-0.03), NTGR: 32.12 (+0.62)
Akers Biosciences Features on Global Broadcast & Online Media
GlobeNewswire - Tue Sep 16, 11:45AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that its Executive Chairman, Raymond F. Akers Jr., Ph.D, was featured on "The RedChip Money Report: Small Stocks Big Money" television program which was televised on Fox Business nationwide as well as Bloomberg Europe, UK and Asia. A recording of the globally transmitted interview regarding Akers Biosciences' business can be viewed here: http://youtu.be/5ymviBu1kno.
AKER: 3.55 (-0.03)
Police and Employers May Finally See Cannabis Breathalyzer
ACCESSWIRE - Wed Sep 10, 8:47AM CDT
Whitefish, MT / September 10, 2014 / The gradual proliferation of alcohol breathalyzer technology has helped bring down the per unit price so far that professional-grade technology, like the kind developed by Akers Biosciences, Inc. (NASDAQ: AKER), is now being marketed directly to consumers. Touted as a safety measure, as well as a means of avoiding the high cost and complications of a DUI/DWI, alcohol breathalyzers are becoming a proactive tool, used by consumers to help them more confidently enjoy an intoxicating product on their own terms.
AKER: 3.55 (-0.03), BED.VN: 0.650 (+0.010), TWD.VN: 1.930 (+0.040)
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Tue Sep 09, 1:34PM CDT
RedChip Companies, Inc. ("RedChip"
IQNT: 13.26 (+0.03), AKER: 3.55 (-0.03)
Akers Biosciences Presenting at US Investor Conferences
GlobeNewswire - Tue Sep 09, 12:43PM CDT
Executive Chairman Raymond F. Akers Jr., Ph.D, to present at:
AKER: 3.55 (-0.03)
Akers Biosciences Announces $864,000 Sales Contract for Its Rapid Results Point of Care Cholesterol Test
GlobeNewswire - Tue Sep 09, 6:30AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"
AKER: 3.55 (-0.03)
RedChip Issues Research Update on Akers Biosciences
GlobeNewswire - Mon Aug 18, 9:10AM CDT
RedChip Companies, Inc., today announced it has issued a research update on Akers Biosciences Inc. (Nasdaq:AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products.
AKER: 3.55 (-0.03)
Akers Biosciences Reports Its Second Quarter Financial Results
GlobeNewswire - Tue Aug 12, 6:09AM CDT
Sales of flagship PIFA Heparin/PF4 products increasing
AKER: 3.55 (-0.03)
Akers Biosciences Announces Conference Call to Discuss Its Second Quarter and Six Months Financial Results
GlobeNewswire - Mon Aug 11, 11:17AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"
AKER: 3.55 (-0.03)
Akers Appoints New Vice President of International Sales and Marketing to Build International Business
GlobeNewswire - Tue Aug 05, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"
AKER: 3.55 (-0.03), AKR: 29.67 (+0.28)
Akers Biosciences Signs Feasibility Study Deal With Konica Minolta to Develop Rapid Test to Aid Heart Attack Diagnoses
GlobeNewswire - Mon Jul 28, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"
AKER: 3.55 (-0.03), AKR: 29.67 (+0.28)
US Patent Granted for Akers' Breath Ketone Detection Device
GlobeNewswire - Thu Jul 17, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"
AKER: 3.55 (-0.03), AKR: 29.67 (+0.28)
Akers to Ring Today's NASDAQ Closing Bell
GlobeNewswire - Wed Jul 09, 7:09AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "ABI"
AKER: 3.55 (-0.03), AKR: 29.67 (+0.28), NDAQ: 41.19 (+0.45)
RedChip Issues Research Profile on Akers Biosciences
GlobeNewswire - Tue Jul 08, 9:03AM CDT
RedChip Companies, Inc., today announced it has issued a research profile on Akers Biosciences Inc. (Nasdaq:AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products.
AKER: 3.55 (-0.03)
Akers Biosciences Inc (NASDAQ: AKER) to Ring The NASDAQ Stock Market Closing Bell
GlobeNewswire - Tue Jul 08, 9:00AM CDT
What:
AKER: 3.55 (-0.03), NDAQ: 41.19 (+0.45)
Akers Biosciences Signs Agreement With Medline -- a Major US Distributor
GlobeNewswire - Wed Jun 25, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "ABI"
AKER: 3.55 (-0.03), AKR: 29.67 (+0.28)
Akers Biosciences Announces Its Financial Results for Fiscal 2013
GlobeNewswire - Fri Mar 28, 6:00AM CDT
Akers Biosciences, Inc. (AKR.L) (Nasdaq:AKER), (the "Company" or "Akers"
AKER: 3.55 (-0.03)
Leading Medical Sales and Marketing Executive to Spearhead Akers Biosciences' Commercialization Strategy
GlobeNewswire - Thu Mar 27, 6:00AM CDT
Akers Biosciences, Inc. (LSE:AKR) (Nasdaq:AKER), (the "Company" or "ABI"
AKER: 3.55 (-0.03), AKR: 29.67 (+0.28)
Akers Biosciences Co-Founder and Executive Chairman to Assume Duties of President & CEO
GlobeNewswire - Wed Mar 12, 12:15PM CDT
Akers Biosciences, Inc. (LSE:AKR) (Nasdaq:AKER), (the "Company" or "ABI"
AKER: 3.55 (-0.03), AKR: 29.67 (+0.28)